GSA Capital Partners LLP Buys Shares of 3,455 Utah Medical Products, Inc. (NASDAQ:UTMD)

GSA Capital Partners LLP acquired a new position in Utah Medical Products, Inc. (NASDAQ:UTMD) during the 3rd quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The firm acquired 3,455 shares of the medical instruments supplier’s stock, valued at approximately $231,000. GSA Capital Partners LLP owned 0.10% of Utah Medical Products as of its most recent SEC filing.

Several other large investors have also added to or reduced their stakes in the company. Vanguard Group Inc. boosted its stake in Utah Medical Products by 7.3% during the first quarter. Vanguard Group Inc. now owns 183,141 shares of the medical instruments supplier’s stock worth $13,023,000 after buying an additional 12,402 shares during the period. Price T Rowe Associates Inc. MD raised its holdings in shares of Utah Medical Products by 4.3% in the first quarter. Price T Rowe Associates Inc. MD now owns 22,941 shares of the medical instruments supplier’s stock worth $1,632,000 after buying an additional 947 shares during the last quarter. Brandes Investment Partners LP raised its stake in shares of Utah Medical Products by 66.2% in the second quarter. Brandes Investment Partners LP now owns 116,524 shares of the medical instruments supplier’s stock worth $7,789,000 after purchasing an additional 46,427 shares during the last quarter. Sequoia Financial Advisors LLC acquired a new stake in Utah Medical Products during the 2nd quarter worth about $307,000. Finally, American Century Companies Inc. lifted its stake in shares of Utah Medical Products by 18.1% in the 2nd quarter. American Century Companies Inc. now owns 11,921 shares of the medical instruments supplier’s stock valued at $796,000 after purchasing an additional 1,830 shares during the period. Hedge funds and other institutional investors own 69.60% of the company’s stock.

Utah Medical Products Stock Performance

UTMD opened at $65.29 on Monday. The stock has a market capitalization of $221.33 million, a P/E ratio of 15.29 and a beta of 0.08. Utah Medical Products, Inc. has a one year low of $63.38 and a one year high of $87.21. The business’s 50-day simple moving average is $65.88 and its 200-day simple moving average is $67.22.

Utah Medical Products Increases Dividend

The firm also recently declared a quarterly dividend, which will be paid on Friday, January 3rd. Investors of record on Monday, December 16th will be paid a dividend of $0.305 per share. The ex-dividend date of this dividend is Monday, December 16th. This represents a $1.22 dividend on an annualized basis and a yield of 1.87%. This is a boost from Utah Medical Products’s previous quarterly dividend of $0.30. Utah Medical Products’s dividend payout ratio is currently 28.10%.

Wall Street Analyst Weigh In

Separately, StockNews.com lowered shares of Utah Medical Products from a “strong-buy” rating to a “buy” rating in a research note on Thursday, November 7th.

About Utah Medical Products

Utah Medical Products, Inc develops, manufactures, and distributes medical devices for the healthcare industry worldwide. It offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems.